Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
Graefe's Archive for Clinical and Experimental Ophthalmology Nov 08, 2019
Hara C, Wakabayashi T, Fukushima Y, et al. - Researchers undertook this retrospective, interventional, consecutive case series, to determine the features of patients who contracted tachyphylaxis on repeated intravitreal aflibercept (IVA) injections for neovascular age-related macular degeneration (AMD) as well as the frequency of tachyphylaxis. This study included 313 eyes (313 patients) with treatment-naïve AMD with resolution attained soon following the initiation of IVA and observed for ≥ 12 months. They examined the eyes for tachyphylaxis to aflibercept. Findings revealed that a minority of patients with AMD developed tachyphylaxis after repeated IVA injections for the long term, and the possibility of its occurrence was more in eyes with lesions beneath the retinal pigment epithelium and no intraretinal edema. Treatment of AMD should be conducted considering this fact while taking into account the consecutive treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries